Suppr超能文献

酵母液泡作为大鼠大肠杆菌菌血症抗菌剂的疗效

Efficacy of Yeast' Vacuoles as Antimicrobial Agents to Escherichia coli Bacteremia in Rat.

作者信息

Yoon Jihee, Cho Ho-Seong, Park Chul, Park Byoung-Yong, Kim Yang-Hoon, Min Jiho

机构信息

Division of Chemical Engineering, Chonbuk National University, 664-14 Duckjin-dong, Jeonju, 561-756, South Korea.

Bio-Safety Research Institute and College of Veterinary Medicine, Chonbuk National University, 664-14 Duckjin-dong, Jeonju, 561-756, South Korea.

出版信息

Curr Microbiol. 2017 Jan;74(1):22-27. doi: 10.1007/s00284-016-1146-1. Epub 2016 Oct 18.

Abstract

Yeast vacuoles, lysosomes, are cell organelles that have antimicrobial activity against several bacteria in vitro. Lysosomes have a potential application to the treatment of pathogens such as antibiotics in vivo. Therefore, the in vivo efficacy of lysosomes was examined in a rat infection model against pathogenic Escherichia coli with varying susceptibilities to standard antimicrobial agents. Before in vivo testing, the concentration-dependent safety of lysosomes was confirmed by blood test and histopathology of normal rats. The therapeutic efficacy of lysosomes was examined in terms of the survival of E. coli in infected rat blood. The complete blood count and histopathology results were affected by the lysosomes concentration. In addition, the E. coli growth was inhibited by the initial injection of lysosomes. These results support the use of lysosomes as a bacterial inhibitor of an infected rat model.

摘要

酵母液泡即溶酶体,是在体外对多种细菌具有抗菌活性的细胞器。溶酶体在体内有作为抗生素等病原体治疗手段的潜在应用价值。因此,在大鼠感染模型中研究了溶酶体对致病性大肠杆菌的体内疗效,这些大肠杆菌对标准抗菌剂的敏感性各不相同。在进行体内测试之前,通过对正常大鼠进行血液检测和组织病理学检查,确认了溶酶体的浓度依赖性安全性。根据感染大鼠血液中大肠杆菌的存活情况来检测溶酶体的治疗效果。全血细胞计数和组织病理学结果受溶酶体浓度的影响。此外,最初注射溶酶体可抑制大肠杆菌的生长。这些结果支持将溶酶体用作感染大鼠模型的细菌抑制剂。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验